Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
BrevaRex MAb-AR20.5 by OncoQuest for Pancreatic Cancer: Likelihood of Approval
BrevaRex MAb-AR20.5 is under clinical development by OncoQuest and currently in Phase I for Pancreatic Cancer. According to GlobalData, Phase...